FIXX - Homology Medicines GAAP EPS of -$0.60 misses by $0.07 revenue of $0.82M misses by $0.1M
2023-03-09 17:55:07 ET
- Homology Medicines press release ( NASDAQ: FIXX ): Q4 GAAP EPS of -$0.60 misses by $0.07 .
- Revenue of $0.82M (+2.5% Y/Y) misses by $0.1M .
For further details see:
Homology Medicines GAAP EPS of -$0.60 misses by $0.07, revenue of $0.82M misses by $0.1M